Primary study · included by 1 review

Neoadjuvant Chemoimmunotherapy for the Treatment of Locally Advanced Head and Neck Squamous Cell Carcinoma: A Single-Arm Phase 2 Clinical Trial.

Zhang 2022 · Zhang Zhanjie, Wu Bian, Peng Gang, et al. · Clinical cancer research : an official journal of the American Association for Cancer Research · 2022

Included by

The Efficacy and Safety of Neoadjuvant Immunotherapy in Pan-Squamous Cell Carcinomas: A Meta-Analysis of Esophageal, Head and Neck, Cervical, Lung, Cutaneous, and Oral Squamous Cell Carcinomas.

Non-Cochrane · intervention · 2026 · cited as Zhang 2022 · Supplementary Table S1; reference list

The review does not say which of its outcomes this study informs.

1 including review in total.